Explore

Rapid Read Rapid Read
Science Corp to Test First Human Brain Sensor with Yale Neurosurgeon

Science Corp to Test First Human Brain Sensor with Yale Neurosurgeon

Science Corporation, founded by former Neuralink president Max Hodak, is set to test its first human brain sensor in collaboration with Yale neurosurgeon Murat Günel. The sensor, a pea-sized device with 520 electrodes, will be placed on the brain's surface during scheduled surgery for an unrelated condition. This marks a significant step in the company's biohybrid brain-computer interface project, which aims to integrate lab-grown neurons with electronic components. The trial is expected to begin in 2027, with the initial focus on safety and signal recording capabilities.
Trendline Trendline
Biotech Companies Alamar, Hemab, Kailera, and Seaport Advance IPO Plans on Nasdaq

Biotech Companies Alamar, Hemab, Kailera, and Seaport Advance IPO Plans on Nasdaq

Biotech Companies Alamar, Hemab, Kailera, and Seaport Advance IPO Plans on Nasdaq
Rapid Read Rapid Read
New Technology Offers Hope for Parkinson's Patients with Adaptive Deep Brain Stimulation

New Technology Offers Hope for Parkinson's Patients with Adaptive Deep Brain Stimulation

A new technology is providing hope for individuals suffering from Parkinson's disease, a condition affecting over a million Americans. The technology, known as adaptive deep brain stimulation, is being highlighted by NBC News' Dr. Akshay Syal. This innovative approach involves the use of a device that adjusts its stimulation in response to the patient's brain activity, potentially improving the management of symptoms. The report includes an interview with a woman diagnosed with Parkinson's in her 30s, who shares how this technology has significantly impacted her life. The adaptive nature of the device allows for more personalized treatment, which could lead to better outcomes for patients.
Trendline Trendline
Humanetics Corporation to Present Radiation Countermeasure at Investor Conference

Humanetics Corporation to Present Radiation Countermeasure at Investor Conference

Humanetics Corporation to Present Radiation Countermeasure at Investor Conference
Trendline Trendline
Kelun-Biotech Presents Promising Results for Sacituzumab Tirumotecan in Gynecologic Oncology

Kelun-Biotech Presents Promising Results for Sacituzumab Tirumotecan in Gynecologic Oncology

Kelun-Biotech Presents Promising Results for Sacituzumab Tirumotecan in Gynecologic Oncology
Trendline Trendline
Midwest Metros Ranked for Tech Workforce Success

Midwest Metros Ranked for Tech Workforce Success

Midwest Metros Ranked for Tech Workforce Success
Trendline Trendline
No Doubt Guitarist Tom Dumont Reveals Parkinson's Diagnosis Amid Upcoming Performances

No Doubt Guitarist Tom Dumont Reveals Parkinson's Diagnosis Amid Upcoming Performances

No Doubt Guitarist Tom Dumont Reveals Parkinson's Diagnosis Amid Upcoming Performances
Trendline Trendline
Miracell Achieves FDA Clearance for Advanced Cell Concentration Systems

Miracell Achieves FDA Clearance for Advanced Cell Concentration Systems

Miracell Achieves FDA Clearance for Advanced Cell Concentration Systems
Trendline Trendline
BioNTech and DualityBio Report Promising Results in Mid-Stage Endometrial Cancer Trial

BioNTech and DualityBio Report Promising Results in Mid-Stage Endometrial Cancer Trial

BioNTech and DualityBio Report Promising Results in Mid-Stage Endometrial Cancer Trial
Rapid Read Rapid Read
CorTec Receives FDA Breakthrough Designation for Stroke Rehabilitation BCI

CorTec Receives FDA Breakthrough Designation for Stroke Rehabilitation BCI

CorTec has received the FDA's Breakthrough Device Designation for its Brain Interchange system, a brain-computer interface (BCI) designed to support motor recovery in stroke patients. This designation applies to the use of direct cortical electrical stimulation to treat chronic stroke-related impairments, marking the first BCI globally to receive this recognition specifically for stroke motor rehabilitation. The system combines neural signal recording with adaptive stimulation in a closed-loop architecture, aimed at restoring motor function. It is currently being evaluated in an FDA-approved study at the University of Washington.
Rapid Read Rapid Read
CorTec Receives FDA Breakthrough Designation for Brain-Computer Interface in Stroke Rehabilitation

CorTec Receives FDA Breakthrough Designation for Brain-Computer Interface in Stroke Rehabilitation

CorTec has been granted the 'Breakthrough Device Designation' by the US Food and Drug Administration (FDA) for its Brain Interchange system, a fully implantable brain-computer interface (BCI) aimed at aiding motor recovery in stroke patients. This designation is specifically for the use of direct cortical electrical stimulation to treat chronic stroke-related impairments, marking the first BCI globally to receive such recognition for stroke motor rehabilitation. The FDA's Breakthrough Device program is designed to expedite the development and review of technologies that may offer more effective treatment for life-threatening or irreversibly debilitating conditions. CorTec's system combines neural signal recording with adaptive stimulation in a closed-loop architecture, designed to interpret brain signals and deliver therapeutic stimulation to restore motor function. The platform is currently under evaluation in an FDA-approved investigational device exemption study at the University of Washington in Seattl...
SB Nation SB Nation
No. 8 Maryland men’s lacrosse cruises past Rutgers, 12-2, earns seventh Big Ten title

No. 8 Maryland men’s lacrosse cruises past Rutgers, 12-2, earns seventh Big Ten title

The Terps finished Big Ten play with just one conference loss.